IL17A and cancer: ETBF has been proven to be enriched in CRC patients as a potential cancer-promoting colony, and it was found that Bacteroides fragilis toxin (BFT) and IL-17 produced by ETBF after colonization synergistically activate the STAT3 signaling pathway in IC (18).